
Chromocarbe
CAS No. 4940-39-0
Chromocarbe( Chromocarb )
Catalog No. M14654 CAS No. 4940-39-0
Chromocarb is a vascular protective agent used in the treatment of venous disorders and microvascular affections.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
500MG | 38 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameChromocarbe
-
NoteResearch use only, not for human use.
-
Brief DescriptionChromocarb is a vascular protective agent used in the treatment of venous disorders and microvascular affections.
-
DescriptionChromocarb is a vascular protective agent used in the treatment of venous disorders and microvascular affections. Peroral treatment of rats with Chromocarb significantly reduces the degradation of the vascular wall by intravenous collagenase. Chromocarb treatment induces a lesser permeability increase of the BBB, a shorter recovery time, lower hydroxyproline levels in the cerebrospinal fluid and a lesser decrease of the collagen content of the brain capillary basal lamina.
-
In Vitro——
-
In Vivo——
-
SynonymsChromocarb
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number4940-39-0
-
Formula Weight190.15
-
Molecular FormulaC10H6O4
-
Purity>98% (HPLC)
-
SolubilityDMSO: 38 mg/mL (199.84 mM)
-
SMILESO=C(C1=CC(C2=CC=CC=C2O1)=O)O
-
Chemical Name4-Oxo-4H-1-benzopyran-2-carboxylic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Godeau G, et al. Clin Physiol Biochem, 1987, 5(1), 15-26.
molnova catalog



related products
-
Glaucine
Glaucine has antitussive antioxidative potential and antiviral activities it may be an anti-arthritic agent it can enhance LPS and zymosan-induced IL-10 production. Glaucine can inhibit the migration and invasion of human breast cancer cells by MMP-9 inhibitory activity attenuating IκBα and NF-κB activities.
-
Coixol
Coixol acts as a central muscle relaxant with an anti-convulsant effect.
-
Urelumab
Urelumab(BMS-66513) is a humanized IgG4 monoclonal antibody, often used as a CD137 agonist.